Blog
-
From Innovation to Injury – The Rise and Fall of the Cartiva Toe Implant
The Rise and Fall of the Cartiva Toe Implant When the Cartiva Synthetic Cartilage Implant was first introduced, it was hailed as a major step forward in orthopedic medicine-a simple, less invasive way to restore mobility for patients suffering from arthritis in the big toe joint. It promised the best of both worlds: relief without…
-
Why the Cartiva Recall Could Be Bigger Than Anyone Expected
The Expanding Fallout from the Cartiva Recall When Stryker Corporation announced a nationwide recall of the Cartiva Synthetic Cartilage Implant in late 2024, it seemed at first like a limited correction-a product quietly withdrawn due to “performance concerns.” But as more information emerges, it’s becoming clear that this is no ordinary recall. The number of…
-
Emerging Mass Tort: Dupixent and the Link to Rare Skin Cancer (CTCL)
Emerging Mass Tort: Dupixent and the Link to Rare Skin Cancer (CTCL) The FDA’s safety investigation into Dupixent and its potential link to Cutaneous T-Cell Lymphoma (CTCL) has created a storm of concern among patients, physicians, and attorneys nationwide. Dupixent (dupilumab) has long been marketed as a breakthrough for moderate to severe atopic dermatitis. But…
-
Dupixent and Cancer: Understanding the Four-Fold Increased Risk
Dupixent and Cancer: Understanding the Four-Fold Increased Risk Recent medical findings have raised alarming questions about the safety of Dupixent, a biologic medication prescribed for chronic skin and respiratory conditions. Data emerging from post-market studies and adverse event reports suggest that patients taking Dupixent may face a four-fold increased risk of developing a rare type…
-
Have You Suffered a Dupixent Injury? Recognizing the Warning Signs of CTCL
Have You Suffered a Dupixent Injury? Recognizing the Warning Signs of CTCL Dupixent injury cases are becoming more common as patients report worsening skin conditions months or even years after beginning treatment. For many, Dupixent initially brings tremendous relief from eczema or dermatitis, but over time, some begin to experience persistent, painful, or changing rashes…
-
Why Misdiagnosed Eczema Cases Are Among the Strongest Dupixent Claims
Why Misdiagnosed Eczema Cases Are Among the Strongest Dupixent Claims Across the growing landscape of Dupixent claims, one pattern stands out as particularly powerful: patients who were told they had chronic eczema, but later learned they were battling cutaneous T-cell lymphoma (CTCL) all along. These misdiagnosed eczema cases are not only tragic – they are…
-
Failure to Warn: Did Dupixent’s Manufacturer Neglect Critical Safety Information?
Failure to Warn: Did Dupixent’s Manufacturer Neglect Critical Safety Information? The controversy surrounding Dupixent’s failure to warn of potential cancer risks has placed the drug’s manufacturer under significant legal and public scrutiny. Dupixent (dupilumab), widely prescribed for eczema, asthma, and other inflammatory conditions, has become one of the most profitable biologic drugs on the market.…
-
Who Is Most at Risk? Dupixent Use Among Older and Long-Term Patients
Who Is Most at Risk? Dupixent Use Among Older and Long-Term Patients Dupixent risks are becoming an increasing concern among older adults and patients who have been using the drug for extended periods. While Dupixent (dupilumab) has provided relief to many suffering from eczema, asthma, and chronic sinus conditions, mounting reports suggest that prolonged immune…
-
Dupixent’s Medical Uses and Associated Risks
Understanding Dupixent’s Medical Uses and Associated Risks Dupixent (generic name dupilumab) has become one of the most widely prescribed medications for chronic inflammatory conditions such as eczema, asthma, and sinusitis. Marketed as a breakthrough treatment, it works by targeting specific immune pathways to reduce inflammation. However, as its use expands, concerns have emerged about the…
-
Inside the FDA Investigation: What the Safety Signal on Dupixent Really Means
Inside the FDA Investigation: What the Safety Signal on Dupixent Really Means The FDA’s investigation into Dupixent has drawn national attention, raising questions about the drug’s safety profile and what the discovery of a “safety signal” really means for patients who rely on this medication. Dupixent, approved to treat eczema, asthma, and other inflammatory conditions,…
Speak with An Attorney
Submit This Form or Call 800-403-6191